NEWBURY, England, May 16, 2024 /PRNewswire/ -- Osteotec, the
market-leading manufacturer and distributor of medical devices, is
pleased to announce a new partnership with SI-BONE to exclusively
distribute the iFuse Implant System® in the UK and Ireland.
The strategic relationship is the newest addition to Osteotec's
rapidly expanding offering to customers, which provides surgeons
with innovative solutions.
San Jose, California-based
SI-BONE are at the forefront of advancing minimally invasive
procedures for the sacroiliac (SI) joint. The iFuse Implant System®
is designed to provide immediate SI joint stabilisation and allow
long-term fusion.
To date, more than 55,000 minimally invasive surgical SI joint
fusions have been performed with the iFuse Implant System® by more
than 2,400 surgeons worldwide.
"We are pleased to be expanding our product offering to include
the iFuse Implant System®, and to be working with the UK's top
spine surgeons to give them more options, expand our treatment
offering and deliver better patient outcomes," said Dean Stockwell, Osteotec Sales & Marketing
Director.
"Our customers have come to anticipate forward-thinking
solutions from Osteotec, and this is just one more example of how
we are increasing patient treatment options through investment in
partnerships with manufacturers who share our values.
"We look forward to working with the SI-BONE team to increase
and support sales through our expertise, ensuring our customers
enjoy the best possible experience, service, and support in the
industry."
The SI joint is one of the most under-served, under-diagnosed,
and under-treated areas in orthopaedics. The iFuse Implant System
is intended for sacroiliac fusion for conditions including
sacroiliac joint dysfunction that is a direct result of sacroiliac
joint disruption and degenerative sacroiliitis.
It is anticipated that the agreement, which went into effect on
April 1, 2024, will contribute to
substantial increases in sales and revenue and accelerate
growth.
"We are excited about working with Osteotec to expand our
footprint in the UK and Ireland,"
said Neville Lorimer, SI-BONE Vice
President, International.
"With the assistance of Osteotec's talented commercial team and
extensive industry knowledge, we will be able to accelerate our
strategic objective of providing superior patient outcomes in these
markets."
The two organisations look forward to combining their expertise
and technologies to maximise marketing opportunities, increase
productivity and improve healthcare outcomes.
"This exclusive distribution agreement builds upon the shared
values of both companies and will give our customers more focused
support than ever before," said Dean
Stockwell. "We are pleased to be collaborating with an
organisation that values excellence as much as we do."
Editor's Notes
About Osteotec
Osteotec is a manufacturer and distributor of medical devices
headquarter in Newbury, UK, with
offices in Dublin and Malmö.
Established in 1993, Osteotec has been supplying into the NHS and
private healthcare sectors for the past 31 years.
Osteotec manufactures and distributes the Osteotec Silicone
Finger, ChiroKlip and the Concentric Bone Graft System and is the
exclusive UK distributor for world-leading orthopaedic partners
including SI-BONE, TriMed, Enovis and Mathys.
Media Contact:
Ric Sumner
Head of Marketing
ric.sumner@osteotec.com | 020 3011 5574
For more information, visit – www.osteotec.com
About SI-BONE
SI-BONE is a global leader in technology for surgical
treatment of musculoskeletal disorders of the sacropelvic anatomy.
Since pioneering minimally invasive surgery of the SI joint in
2009, SI-BONE has supported over 3,600 surgeons in
performing a total of more than 95,000 sacropelvic procedures. A
unique body of clinical evidence supports the use of SI-BONE's
technologies, including two randomized controlled trials and over
125 peer reviewed publications. SI-BONE has leveraged its
leadership in minimally invasive SI joint fusion to commercialize
novel solutions for adjacent markets, including adult deformity,
spinopelvic fixation, and pelvic trauma.
For additional information on the company or the products
including risks and benefits, please
visit www.si-bone.com.
Logo:
https://mma.prnewswire.com/media/2151731/4710757/Osteotec_Logo.jpg
View original
content:https://www.prnewswire.co.uk/news-releases/osteotec-announces-exclusive-uk-and-ireland-distribution-agreement-with-si-bone-302147856.html